Skip to main content

Dynamic potassium variability (K-CV) as an independent predictor of mortality in maintenance hemodialysis

Journal
Renal failure (Q1)
Published
6 September 2026
Study design
Retrospective cohort
Evidence level
Level 3, Low (CEBM 3b)
Authors
Yeping Ma, Xiaojing Liu, Xiaoqi Wang, Li Zhongxin
PMID
42702576
DOI
10.1080/0886022X.2026.2664912

Why clinicians should know about it

  • Picked for Nephrology (paper of the day, 10 September 2026): Potassium variability predicts mortality in maintenance hemodialysis

Abstract

Serum potassium fluctuations are common but understudied in maintenance hemodialysis (MHD) patients. This retrospective cohort study investigated the association between serum potassium variability, measured by the coefficient of variation (K-CV), and all-cause mortality in 201 MHD patients. Patients were divided into low and high K-CV groups according to the median K-CV cutoff and followed for a median of 72 months. Multivariate Cox regression, adjusted for confounders, revealed that patients in the high K-CV group had a significantly increased mortality risk compared to the low K-CV group (adjusted HR = 1.537, 95% CI: 1.026-2.302, p = 0.037). When analyzed continuously, log(K-CV) showed a strong dose-response relationship with mortality (HR = 7.627, p = 0.010). Subgroup analyses indicated this association was particularly pronounced in patients with lower inflammation and better nutritional status. These findings demonstrate that K-CV, a marker of serum potassium variability, serves as an independent predictor of all-cause mortality in MHD patients. Its prognostic value supports the use of K-CV for risk stratification to identify high-risk patients requiring intensive monitoring and tailored potassium management strategies in dialysis care.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.